SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-387564"
 

Sökning: id:"swepub:oai:DiVA.org:uu-387564" > Secretoneurin Is an...

  • Ottesen, Anett H.Akershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)

Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • Lippincott Williams & Wilkins,2019
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-387564
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-387564URI
  • https://doi.org/10.1161/CIRCEP.118.007045DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND: Circulating SN (secretoneurin) concentrations are increased in patients with myocardial dysfunction and predict poor outcome. Because SN inhibits CaMKII delta (Ca2+/calmodulin-dependent protein kinase II delta) activity, we hypothesized that upregulation of SN in patients protects against cardiomyocyte mechanisms of arrhythmia. METHODS: Circulating levels of SN and other biomarkers were assessed in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT; n=8) and in resuscitated patients after ventricular arrhythmia-induced cardiac arrest (n=155). In vivo effects of SN were investigated in CPVT mice (RyR2 [ryanodine receptor 2]-R2474S) using adeno-associated virus-9-induced overexpression. Interactions between SN and CaMKII delta were mapped using pull-down experiments, mutagenesis, ELISA, and structural homology modeling. Ex vivo actions were tested in Langendorff hearts and effects on Ca2+ homeostasis examined by fluorescence (fluo-4) and patchclamp recordings in isolated cardiomyocytes. RESULTS: SN levels were elevated in patients with CPVT and following ventricular arrhythmia-induced cardiac arrest. In contrast to NT-proBNP (N-terminal proB- type natriuretic peptide) and hs-TnT (high-sensitivity troponin T), circulating SN levels declined after resuscitation, as the risk of a new arrhythmia waned. Myocardial pro-SN expression was also increased in CPVT mice, and further adeno-associated virus-9-induced overexpression of SN attenuated arrhythmic induction during stress testing with isoproterenol. Mechanistic studies mapped SN binding to the substrate binding site in the catalytic region of CaMKII delta. Accordingly, SN attenuated isoproterenol induced autophosphorylation of Thr287-CaMKII delta in Langendorff hearts and inhibited CaMKII delta-dependent RyR phosphorylation. In line with CaMKII delta and RyR inhibition, SN treatment decreased Ca2+ spark frequency and dimensions in cardiomyocytes during isoproterenol challenge, and reduced the incidence of Ca2+ waves, delayed afterdepolarizations, and spontaneous action potentials. SN treatment also lowered the incidence of early afterdepolarizations during isoproterenol; an effect paralleled by reduced magnitude of L-type Ca2+ current. CONCLUSIONS: SN production is upregulated in conditions with cardiomyocyte Ca2+ dysregulation and offers compensatory protection against cardiomyocyte mechanisms of arrhythmia, which may underlie its putative use as a biomarker in at-risk patients.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Carlson, Cathrine R.Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Eken, Olav SovikOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Sadredini, ManiOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Myhre, Peder L.Akershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Shen, XinOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Dalhus, BjornOslo Univ Hosp, Clin Lab Med, Dept Microbiol, Oslo, Norway;Univ Oslo, Inst Clin Med, Dept Med Biochem, Oslo, Norway (författare)
  • Laver, Derek R.Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia;Hunter Med Res Inst, Callaghan, NSW, Australia (författare)
  • Lunde, Per KristianOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Kurola, JouniKuopio Univ Hosp, Div Intens Care Med, Kuopio, Finland (författare)
  • Lunde, MarianneOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Hoff, Jon ErikAkershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway (författare)
  • Godang, KristinOslo Univ Hosp, Dept Endocrinol, Sect Specialized Endocrinol, Oslo, Norway (författare)
  • Sjaastad, IvarOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway;Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway (författare)
  • Pettila, VilleUniv Helsinki, Div Anesthesiol Intens Care & Pain Med, Helsinki, Finland;Helsinki Univ Hosp, Helsinki, Finland (författare)
  • Stridsberg, MatsUppsala universitet,Institutionen för medicinska vetenskaper(Swepub:uu)matsstri (författare)
  • Lehnart, Stephan E.Univ Med Ctr Goettingen, Heart Res Ctr Goettingen, Gottingen, Germany (författare)
  • Edwards, Andrew G.Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway;Simula Res Lab, Fornebu, Norway (författare)
  • Lunde, Ida G.Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Omland, TorbjornAkershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Stokke, Mathis K.Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Christensen, GeirOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway;Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway (författare)
  • Rosjo, HelgeAkershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (författare)
  • Louch, William E.Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway;Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway (författare)
  • Akershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, NorwayOslo Univ Hosp, Inst Expt Med Res, Oslo, Norway;Univ Oslo, Ctr Heart Failure Res, Oslo, Norway (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Circulation: Lippincott Williams & Wilkins12:41941-31491941-3084

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy